Torres VE. Polycystic kidney disease autosomal-dominant and recessive forms. In: Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 896–904.
Fick GM, Johnson AM, Hammomd WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5:2048–56.
PubMed
CAS
Google Scholar
Peter CH, Vicente ET. Autosomal dominant polycystic kidney disease. Gene reviews. Bethesda: National Institutes of Health; 2009.
Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, et al. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Prac. 2009;112:c157–63.
Article
CAS
Google Scholar
Elzinga LW, Bennett WM. Miscellaneous renal and systemic complications of autosomal dominant polycystic kidney disease including infection. In: Watson ML, Torres VE, editors. Polycystic kidney disease. Northants: Oxford Medical; 1996. p. 483–99.
Google Scholar
Levine E, Grantham JJ. The role of computed tomography in the evaluation of adult polycystic kidney disease. Am J Kidney Dis. 1981;1:99–105.
PubMed
CAS
Google Scholar
Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987;82:714–8.
PubMed
Article
CAS
Google Scholar
Amesur P, Castronuovo JJ, Chandramouly B. Infected cyst localization with gallium SPECT imaging in polycystic kidney disease. Clin Nucl Med. 1988;13:35–7.
PubMed
Article
CAS
Google Scholar
Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003;41:E18–21.
PubMed
Article
Google Scholar
Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1183–9.
PubMed
Article
Google Scholar
Laffon E, Cazeau AL, Monet A, de Clermont H, Fernandez Z, Marthan R et al. The effect of renal failure on
18F-FDG uptake: a theoretic assessment. J Nucl Med Technol 2008;36(4):200–2.
Google Scholar
Ichioka K, Saito R, Matsui Y, Terai A. Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology. 2007;70(6):1219.
PubMed
Article
Google Scholar
Katano K, Kakuchi Y, Nakashima A, Takahashi S, Kawano M. Efficacy of diffusion-weighted magnetic resonance imaging in detecting infected cysts in a case of polycystic kidney disease. Clin Nephrol. 2011;75:S24–6.
Google Scholar
Verswijvel G, Vandecaveye V, Gelin G, Vandevenne J, Grieten M, Horvath M, et al. Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. JBR-BTR. 2002;85(2):100–3.
PubMed
CAS
Google Scholar
Carragee E, Eugene J. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine. 1997;22(7):780–5.
PubMed
Article
CAS
Google Scholar
Ryan A, McCook B, Sholosh B, Pryma DA, Jablonowski E, Fuhrman C, et al. Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT. Clin Nucl Med. 2007;32:729–31.
PubMed
Article
Google Scholar
Repko BM, Tulchinsky M. Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med. 2008;33:651–3.
PubMed
Article
Google Scholar
Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, et al. Positron-emission computed tomoghraphy in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:1644–50.
PubMed
Article
Google Scholar
Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6:96–106.
PubMed
Article
CAS
Google Scholar
Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2010;55:916–22.
PubMed
Article
Google Scholar
Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:2229–41.
PubMed
Article
Google Scholar
Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med. 2011;39:1792–9.
PubMed
Article
CAS
Google Scholar
Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322–31.
PubMed
Article
Google Scholar
Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210–7.
PubMed
Article
CAS
Google Scholar